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Abstract
Purpose To determine whether the sensitivity and specificity of four-dimensional CTA (4D-CTA) are equivalent to digital subtraction
angiography (DSA) in the detection of underlying vascular abnormalities in patients with intracerebral haemorrhage (ICH).
Methods A systematic review of studies comparing 4D-CTAwith DSA in the detection of the underlying structural causes of
ICH was performed on the literature published between 1998 and 2019.
Results We identified a total of 237 articles from PubMed, SCOPUS and Web of Science using the following Medical Subject
Headings (MeSH) terms: primary intracerebral haemorrhage, 4D-CTA, DSA, cerebral haemorrhage, angiography, digital sub-
traction, arteriovenous malformations, 4D, CTA, dynamic-CTA and time-resolved CTA. Following the removal of duplicate
publications and articles failing to meet our inclusion criteria, there were four articles potentially viable for analysis. Therefore,
there were not sufficient studies to provide a statistically meaningful meta-analysis.
Conclusion The review of current literature has demonstrated that there are few published studies comparing 4D-CTAwith DSA
in spontaneous ICH, with only four suitable studies identified for potential analysis. However, due to the restricted number of
patients and high sensitivity and specificity of 3 studies (100%), performing a meta-analysis was not meaningful. Qualitative
analysis of the data concluded that 4D-CTA has the diagnostic potential to replace invasive DSA in certain cases with vascular
abnormalities. However, further research studies directly comparing 4D-CTAwith DSA using larger prospective patient cohorts
are required to strengthen the evidence base.
Key Points
• Two hundred and thirty-seven manuscripts were initially identified
comparing the accuracy of four-dimensional CTA (4D-CTA) with
intra-arterial digital subtraction angiography (IA-DSA) in the
identification of vascular abnormalities in spontaneous ICH.
• Following study screening, only 26 manuscripts remained for further
analysis.
• Few studies were available that met the inclusion criteria for performing
a meta-analysis (n = 4).
• Qualitative analysis of the data has concluded that 4D-CTA has the
diagnostic potential for replacing IA-DSA in many cases with
vascular abnormalities.
• Further large-scale studies are required to be performed that directly
compare the sensitivity and specificity of 4D-CTAwith IA-DSA in
patients with spontaneous ICH to improve the evidence base.
* C. E. Denby
Christine.Denby@liverpool.ac.uk
1 Neuroradiology Department, The Walton Centre NHS Foundation
Trust, Lower Lane, Fazakerley, Liverpool L9 7LJ, UK
2 Royal Liverpool University Hospital, Liverpool University Hospitals
NHS Foundation Trust, Prescot Street, Liverpool L7 8XP, UK
3 Countess of Chester Hospital NHS Foundation Trust, Liverpool
Road, Chester CH2 1UL, UK




Is four-dimensional CT angiography as effective as digital subtraction
angiography in the detection of the underlying causes
of intracerebral haemorrhage: a systematic review
The Author(s) 2020
Keywords Four-dimensional CTA (4D-CTA) . Digital subtraction angiography (DSA) . Intracerebral haemorrhage (ICH) .
Haemorrhagic stroke . Vascular abnormalities . Systematic review
Abbreviations
4D-CTA Four-dimensional CTA
DSA Digital subtraction angiography
ICH Intracerebral haemorrhage
AVM Arteriovenous malformation
DAVF’s Dural arteriovenous fistulae
MCA Middle cerebral artery
mSv MilliSieverts
PPV Positive predictive value
NPV Negative predictive value
Introduction
Spontaneous primary intracerebral haemorrhage (ICH) ac-
counts for 8–30% of strokes worldwide and is associated with
high mortality (with a rate of approximately 50% within the
first month) and morbidity (dependency rate of 80% present-
ing 6 months from onset) [1–3]. Haematoma expansion fol-
lowing a spontaneous ICH is one of the leading reasons be-
hind this high mortality and morbidity, with the risk of expan-
sion potentially persisting for several hours or even longer
after the index event resulting in further expansion of existing
haematoma, producing neurological deterioration [3].
Although the most common cause of primary ICH is hy-
pertension [4], ICH secondary to treatable underlying cerebro-
vascular pathologies such as aneurysms, arteriovenous
malformations (AVM), dural arteriovenous fistulae (DAVFs)
and arterial and venous system occlusive disease are not un-
common [5], with 15–20% of patients having an underlying
macrovascular cause [6]. The underlying pathologies causing
ICH are complex and require both accurate and timely diag-
nostic workup prior to neuroradiological intervention (e.g.
embolisation) to facilitate the best clinical outcome.
Historically, digital subtraction angiography (DSA) has
been the gold standard for locating vascular abnormalities
and aneurysms, retaining a significant role in planning for
future intervention. Despite DSA being the current gold stan-
dard, there are risks associated with this procedure due to
invasive arterial access and transient or permanent neurologi-
cal complications. Computed Tomography Angiography
(CTA) has the capability to identify the secondary causes of
ICH, such as vascular malformations and arteriovenous fistu-
las, and is minimally invasive compared with DSA [5].
Additionally, CTA can identify patients at high risk of
haematoma expansion, with a marker known as the “spot
sign” [7]. The spot sign predicts the growth of the haematoma
and the potential for a re-bleed, which can determine the risk
of neurological deterioration, clinical outcome and mortality
[8]. There have been significant advances and improvements
in the CTA procedure in recent years, including the introduc-
tion of three-dimensional (3D-CTA) and latterly four-
dimensional CTA (4D-CTA), which have both supplemented
and to some extent replaced DSA in the diagnosis of aneu-
rysms in certain cases, such as those with middle cerebral
artery (MCA) aneurysms [9–11]. 4D-CTA, also known as
time-resolved or dynamic-CTA, is now more readily available
and builds upon the existing 3D-CTA stereoscopic imaging
and has the time-resolution component of DSA for evaluating
cerebral haemodynamics in a variety of cerebrovascular con-
ditions [5]. In addition to 4D-CTA being non-invasive, further
benefits include a reduction in the complications associated
with endovascular procedures such as DSA and shorter acqui-
sition times. This renders the technique an ideal modality for
emergency cases, particularly in patients presenting with a
large haematoma. 4D-CTA also enables the detection of pa-
renchymal abnormalities such as hydrocephalus and brain
haematomas that are difficult to visualise using DSA [12].
However, 4D-CTA is multi-phasic and therefore has previ-
ously been associated with higher radiation doses than the stan-
dard single-phase CTA examinations, although recent advances
in this technique have reduced procedural radiation dose. A study
by Radon et al. [13] demonstrated that the radiation dose can be
potentially reduced by the more precise matching of exposure
duration to cerebral circulation time [13]. The effective radiation
dose in this studywas reduced from 6.9 to 3.4mSv.Other studies
recorded radiation doses of less or equal to 5.3 mSv [12, 14, 15],
which is a significant dose reduction.
Despite 4D-CTA demonstrating great potential in the assess-
ment of AVM and other vascular abnormalities due to time res-
olution, there are still limitations. This review has been per-
formed with the aim of gathering together and evaluating the
literature with aims of performing a meta-analysis in order to
determine whether 4D-CTA is as sensitive and specific as DSA
in the detection of underlying structural abnormalities that are
responsible for haemorrhagic stroke in patients with ICH.
Materials and methods
Design
A systematic review was conducted according to the guide-
lines developed by the Cochrane Database of Systematic
Reviews. The research question was developed using the
PICO framework [16]. The ICH patient group (> 18 years of
age) constituted the Population. The Intervention is 4D-CTA,
with the Comparison technique being DSA. Outcome is the
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correct detection of the underlying cause (vascular abnormal-
ity/lesion) of ICH, sensitivity/specificity analysis and rater
reliability, if available.
Inclusion and exclusion criteria
Inclusion criteria
1. Patients presenting with ICH, symptoms of ICH (AVM,
dAVF, aneurysm, parenchymal bleed, primary ICH)
2. Participants > 18 years of age
3. Studies with > 15 patients
4. Search date between January 1998 to March 2019
5. Randomised controlled trials (RCT), non-RCT, observa-
tional studies
6. Studies with more than one board-certified radiological
reviewer
7. Sensitivity and specificity analysis, positive and negative
predictive values, ROC (inter-rater agreement)
Exclusion criteria
1. Patients presenting with vascular tumours, SAH (sole,
with no evidence of parenchymal haemorrhage), trauma,
ischemic stroke, post-operative neurosurgery
2. Participants < 18 years of age
3. Studies with < 15 patients
4. Manuscript replies, case studies, guidelines, animal/in
vitro studies
5. Studies with only one board-certified radiology reviewer
6. Non-English language studies
Study selection
The PRISMA guidelines were followed for this study. PubMed,
SCOPUS andWeb of Science databases were used to search for
published studies. The search strategy consisted of Medical
Subject Headings (MeSH) terms and text words for primary
intracerebral haemorrhage, 4D-CTA, DSA, cerebral haemor-
rhage, angiography, digital subtraction, arteriovenous




We identified a total of 237 articles. One hundred and twenty-
three studies were identified via PubMed using the following
MeSH terms: primary intracerebral haemorrhage,
spontaneous intracerebral haemorrhage 4D-CTA, DSA, cere-
bral haemorrhage, angiography, digital subtraction, arteriove-
nous malformations, 4D, CTA, dynamic-CTA, time-resolved
CTA and CTA. Fifty-nine articles were retrieved from Scopus,
with 55 articles retrieved fromWeb of Science using identical
search terms as the PubMed review. Duplicate publications
(n = 126) and articles that failed to meet our inclusion criteria
after title and abstract screening were eliminated (n = 85). The
26 studies potentially eligible for further analysis were pub-
lished between 2004 and 2019. Data collection was mainly
retrospective (n = 20), 4 studies were prospective in nature
with a further 2 studies being a clinical audit and a case study
respectively. The majority of studies were single centre (n =
25), with 1 further study being multi-centre. The 26 articles
were potentially viable for analysis based on title and abstract,
and all underwent full review of the text. Of the 26 studies
identified, 22 articles were excluded on the basis of the studies
not performing DSA (n = 8) or 4D-CTA (n = 7), with a further
5 studies failing to use 4D-CTA and DSA as part of the patient
investigations. One study was a service audit, with another
study presenting only case studies. The combination of imag-
ing modalities were as follows: standard CTA and DSA (n =
4), CTA alone (n = 6), 4D-CTA and DSA (n = 5), 4D-CTA
alone (n = 4), CTA, MRA and DSA (n = 4), combined 3D-
rotational angiography (3D-RA) and DSA (n = 1), 3D-CTA
and DSA (n = 1), 4D-DSA and 2D-DSA (n = 1). Sixteen of
the 26 studies used DSA as their gold standard (62%), with 10
studies (38%) opting to use imaging signs or clinical outcome
as their “gold standard”.
Following the evaluation of the papers, there were only 4
potentially eligible manuscripts; Biswas et al. [5], Wang et al.
[12], Willems et al. [15] and Singh et al. [17] for the meta-
analysis, with 91 patients (all studies combined) available for
analysis (Biswas et al. n = 33 patients, Wang and Willems
et al. n = 17 each, with Singh et al. n = 24 patients).
Demographics are presented in Table 1. Due to there being
limited variability in the sensitivity and specificity of 4D-CTA
and DSA in detecting vascular abnormalities (values reached
100% for 3 out of 4 studies), with positive and negative pre-
dictive values also reaching 100%, it was not statistically
meaningful to perform a meta-analysis. Therefore, the data
is presented using only summary statistics and discussed
qualitatively.
Patient demographics
Demographics of the patients meeting the reviews search
criteria
The age range of all individuals across the 4 studies was 20–
80 years. Variability occurred in the time between the initial
4D-CTA examination and the DSA, with the Willems et al.
study [15] having a window of 4–11 h, and the Biswas et al.
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study [5] having a range of 0–50 days between investigations.
Table 2 below presents the protocol and radiation dose re-
ceived by the patient.
Acquisition parameters
Imaging parameters and radiation dose for the 4D-CTA
and DSA acquisitions
The radiation dose for the 4D-CTA was similar across the
Biswas, Wang and Willems studies [5, 12, 15]; the study by
Singh et al. [17] did not present the dose acquired using their
protocol. Three out of the four studies acquired their 4D-CTA
data using an Aquilion One system (Canon Medical Systems
Europe). Two studies presented the mean dose during the
DSA procedure, which were comparable. 4D-CTA dose was
≤ 5.3 mSv in the Wang et al. study [12]. For the Willems et al.
study [15], the dose was recorded as 5.3 mSv or less for the
4D-CTA. The DSA dose in this study was calculated from 4
typical DSA’s, with DSA dose varying between 7.89 and
9.12 mSv. However, it should be noted that the average
radiation doses the patient receives can be complex to record
for both 4D-CTA and DSA modalities and a comparison of
dose between 4D-CTA and DSA is particularly difficult. The
variability in the radiation dose received during DSA is attrib-
uted to the variable fluoroscopy time per vessel studied, the
number of vessels studied, vascular complexity, fluoroscopic
parameters and differences in protocols and equipment type
[15]. The sensitivity, specificity, positive predictive values
(PPV) and negative predictive values (NPV) acquired in the
4 studies comparing the diagnostic ability of 4D-CTA with
DSA in the detection of AVM is presented in Table 3 below.
Sensitivity, specificity, positive predictive values and negative
predictive values of 4D-CTA compared with DSA for the 4
studies
Across the four studies, a total of 91 patients were available
for analysis. Considering the sensitivity and specificity of 4D-
CTA compared with DSA in diagnosing AVM and dAVF,
Biswas et al. [5] performed a retrospective review of a group
of 33 patients. Out of the 33 patients who underwent both

































Full-text articles assessed 
for eligibility
(n = 26)
Full-text articles excluded, 
with reasons #
(n = 22)
Studies included in 
qualitative synthesis
(n = 4)
Fig. 1 Flowchart of the literature
search and study selection of ICH
patients, following the Preferred
Reporting Items for Systematic
Reviews and Meta-Analyses
(PRISMA) guidelines (SAH, sub-
arachnoid haemorrhage; TBI,
traumatic brain injury). *Records
excluded (n = 85) (SAH (n = 27),
TBI (n = 2), case studies (n = 10),
ischemic stroke (n = 6), no 4D-
CTA (n = 14), no DSA (n = 14),
review papers (n = 7), manuscript
response letters (n = 1), non-
neurological condition (n = 2),
non-English (n = 2)). #Records
excluded (n = 22): not performing
DSA (n = 8) or 4D-CTA (n = 7),
with further 5 studies failing to
use 4D-CTA and DSA as part of
the patient investigations. One
study was a service audit, with
another study presenting only
case studies
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tests, 13 patients were diagnosed as having AVM/DAVF by
DSA (10 and 3 respectively). 4D-CTA was able to detect 7
AVM and all 3 DAVF’s. High efficacy (91–100%) was shown
between the 4D-CTA and the DSA examinations, which dem-
onstrated that 4D-CTA (using 320-detector row CT) is both
practical and has comparable diagnostic accuracy to DSA for
diagnosing AVM or DAVF.
However, variability was noted across the studies in the sen-
sitivity of 4D-CTA in the detection of AVM. One hundred per-
cent sensitivity was achieved in the Singh, Wang and Willems
studies [12, 15, 17], whereas the Biswas et al. study [5] had a
sensitivity of 77% for AVM and dural AVF combined. In this
study, the examination of AVM alone resulted in a sensitivity of
70%, and 100% when evaluating DAVF alone. Specificity was
100% for all studies. Positive and negative predictive valueswere
only available for the Biswas and Singh studies [5, 17]. PPVwas
100% for both studies, and NPV was 87% in the Biswas et al.
study [5] and 100% in the Singh study [17]. Detection of AVM
andDAVF alone in the Biswas et al. study [5] yielded an NPVof
88% and 100% respectively.
Summary of the capability of 4D-CTA and DSA in diagnosing
AVM and determining lesion size (Table 4)
The Wang, Willems and Singh studies [12, 15, 17] dem-
onstrated that 4D-CTA had 100% agreement with DSA in
diagnosing an AVM, with all studies reporting that 4D-
CTA and DSAwere equally as accurate in detecting lesion
sizes of < 3 and 3–6 cm. In the Biswas et al. study [5],
both 4D-CTA and DSA detected lesion sizes of 3–6 cm,
in the cases where the size was < 3 cm, 5 4D-CTA and 8
DSA investigations correctly graded the lesion.
Wang et al. [12] demonstrated that in a small patient cohort,
4D-CTA had the ability to detect all lesions, including
Table 2 CT and DSA acquisition parameters and radiation doses (frames per second (fps))
Protocol Author
Biswas et al. Wang et al. Willems et al. Singh et al.
4D-CTA
System Aquilion One Aquilion One Aquilion One Cine Dynamic Multi 4D
Coverage 16 cm 16 cm 16 cm 20 cm
Detector rows 320 × 0.5 mm 320 × 0.5 mm 320 × 0.5 mm 128 × 0.6 mm
Acquisition Time density curve
(TDC) from test injection
Not specified Not specified Not specified
Radiation dose Mean dose, 6.6 mSv
(range, 4–8.3 mSv)
≤ 5.3 mSv ≤ 5.3 mSv Not specified
DSA
System Inova, GE healthcare Infinix, Toshiba Medical Systems,
and ADVANTX LC/LP
(GE Medical Systems)
Infinix, Toshiba Medical Systems,
and ADVANTX LC/LP
(GE Medical Systems)
Allura XPer FB 20/10,
Philips Medical
Systems
Rate 2.5 fps 3 fps 3 fps 6 fps
Radiation dose Mean dose, 4.2 mSv
(2–10 mSv)
Not specified Dose varied between 7.89
& 9.12 mSv
Not specified
Table 1 Demographics of the 4 studies
Demographics Author
Biswas et al. Wang et al. Willems et al. Singh et al.
Number of patients 33 17 17 24
Mean age (years) Not specified 37 38 (± 17) 24.8 (± 9.7)
Age range (years) 22–80 20–59 Not specified 23–35






Modality 4D-CTA and DSA 4D-CTA and DSA 4D-CTA and DSA 4D-CTA and DSA
Number of reviewers 2 (CTA)
2 (DSA), 4 in total
2 3 3
Time between CT and DSA (days) 10 (range 0–50 days) Within 9 days, mean of 1.5 days 4–11 h Not specified
Neuroradiology (2020) 62:273–281 277
location, size, feeding and draining arteries. Readings were
performed by 2 independent raters. In these cases, 4D-CTA
demonstrated an equal ability to DSA for distinguishing the
main feeding arteries in all patients, achieving a sensitivity and
specificity of 100%.
Similarly, the Willems et al. [15] study demonstrated 100%
sensitivity and specificity in their patient group (n= 17) when
comparing 4D-CTA with DSA in patients with an untreated
AVM. Three readers evaluated the image data. 4D-CTA detected
all AVM, however, difficulties with angioarchitectural details
were encountered and were either misinterpreted or missed by
4D-CTA, compared with DSA. However, 4D-CTA was suffi-
ciently accurate for diagnosing and classifying the shunt, al-
though the authors concluded that treatment planning is likely
to benefit from accompanying cross-sectional imaging in a vari-
ety of planes in combination with perfusion maps [15].
Singh et al. [17] evaluated the accuracy of time-resolved
(4D) CTA in comparison with DSA in defining both the mor-
phological and haemodynamic characteristics of AVM re-
quired for patient management. Twenty-one patients with a
clinical suspicion of AVM and 3 post-AVM diagnosis patients
were evaluated in the study. Eighteen patients had a correct
diagnosis of AVM, with 3 diagnosed with an AV fistula.
Following the comparison of the techniques, the sensitivity
and specificity were 100% respectively, with PPV and NPV
also being 100% for both procedures. The Singh study [17]
reported that early venous filling was present in all 21 cases,
independent of nidus size. An accurate distinction between
feeding artery territories was made in cases where the shunt
was detected using 4D-CTA. The authors further noted that
4D-CTA was fully concordant in depicting flow characteris-
tics, venous drainage, and establishment of the site and grade
of venous stenosis. However, limitations were again noted
when examining finer architectural details. Issues highlighted
in this study included impaired spatial and temporal resolution
and reduced SNR when compared with DSA. As noted in the
other three comparative studies, 4D-CTA is accurate when
classifying and identifying major angioarchitecture features
(e.g. arterial feeders, aneurysms, nidus characteristics and ve-
nous drainage), but can encounter issues when evaluating fin-
er angioarchitecture and haemodynamics, which has the po-
tential to be misinterpreted or missed [17].
Discussion
In this study, we conducted an extensive literature review to
determine the number of studies available comparing the ac-
curacy of 4D-CTA with DSA in the detection of potential
underlying vascular causes of spontaneous ICH, for example,
the presence of an AVM. Haemorrhagic stroke resulting from
the rupture of an AVM is a serious clinical complication and is


























































































































































































































































































































































































































































































































278 Neuroradiology (2020) 62:273–281
adults, which can result in functional disabilities or even death
in these patients [12]. AVM and other vascular malformations
are complex, with several treatment options available to pa-
tients, ranging from conservative clinical management, stereo-
tactic radiosurgery, open neurosurgery, endovascular emboli-
zation or a combination of options. It is essential that the AVM
is characterised and diagnosed as quickly as possible to ensure
optimal treatment. Invasive cerebral DSA allows the accurate
analysis of the nidus angioarchitecture enabling the identifica-
tion and distinction of feeding arteries and draining veins pres-
ent in AVMs, due to the high temporal and spatial resolution
present with this technique. However, despite the high resolu-
tion, this technique is invasive in nature, requires extensive
resources and is associated with a small risk of major compli-
cation (≤ 1.3%), which includes mortality (≤ 0.1%) [17]. At
the present time, DSA remains the gold standard for the eval-
uation of cerebral vasculature due to its increased resolution.
To our knowledge, there are no studies available that have
performed a meta-analysis comparing 3D or 4D-CTA with
DSA in the detection of underlying causes of ICH. However,
following the systematic review, it was concluded that there were
few suitable papers available for meta-analysis, with only 4 stud-
ies identified from the review, which aimed to assess the ability
of 4D-CTA in providing comparative morphological and tempo-
ral information of the AVM compared to DSA, to determine
whether 4D-CTA has the potential to replace catheter angiogra-
phy when diagnosing or following-up cerebral AVM’s. We were
unable to include 3D-CTA into the analysis, due to this technique
providing limited information relating to flow dynamics, which
is therefore not equivalent to 4D-CTA.
Meta-analyses performed before the technical develop-
ments of 3D-CTA and 4D-CTA directly compared standard
CTA with DSA in the detection of cerebral aneurysms [18].
Results from this analysis concluded that DSA remained the
gold-standard technique. However, other reviews comparing
CTA with DSA have reported that CTA was as good if not
better thanDSA in diagnosing, excluding and treating cerebral
aneurysms [5, 9], having the added benefits of a reduced risk
of adverse events, improved patient comfort, wider availabil-
ity and cost-effectiveness.
More recent studies have demonstrated an improvement in
the diagnostic accuracy of CTA (3D-CTA and 4D-CTA)
techniques for detecting underlying vascular abnormalities
[5, 9, 15, 19]. The improvement in 4D-CTA combines the
traditional 3D-CTA with the 4th dimension of time to create
a stereoscopic image continuously displaying blood vessels
within the short interval of time taken for one investigation.
Compared with traditional CTA, which cannot identify AVM
vessels during different blood flow phases, 4D-CTA is capa-
ble of displaying vascular lesions in the arterial, capillary and
venous phases of blood flow through its time-resolved tech-
niques and is therefore a reflection of the vessel’s characteris-
tics at each phase [12, 15]. 4D-CTA has the potential to ex-
clude the vascular causes of haematoma in many cases, there-
fore avoiding unnecessary DSA investigations. Other major
advantages of using 4D-CTA as the initial investigation in-
clude the availability of this technique, with many district
general hospitals (DGH) involved in hyperacute stroke care
having modern CT scanners (minimum of 256 detector rows)
that potentially have the capability to run this examination.
This avoids unnecessary patient transfer to specialist centres
for tests unless deemed to be clinically necessary, such as
cases where 4D-CTA indicates that a DSA will be required
as part of the patient’s treatment plan. The wider implementa-
tion of 4D-CTA includes faster diagnosis due to wider avail-
ability and a relatively short scan time, cost-effectiveness, im-
proved anatomical visualisation (increased sensitivity) for
more rapid treatment planning, with reduced morbidity and
mortality compared with DSA. The disadvantages of CTA
are largely historical, including previous reductions in sensi-
tivity in comparison with DSA, reduced availability in DGH,
with older techniques providing incomplete information relat-
ing to flow patterns in some vascular areas, such as the Circle
of Willis [20]. These previous disadvantages have been ad-
dressed and overcome by modern CTA techniques.
Discrepancies noted between 4D-CTA and DSA, as identi-
fied in the Biswas et al. study [5] appeared to be interpretation
errors when primarily reported, as the lesions were detected
following a review of thin section images. Two lesions were
visible on theMIP image, although they had poor visibility and
were more conspicuous on thinner section images. The 100%
specificity in the detection of AVM or DAVF by 4D-CTA in-
dicates that it could be an effective tool in excluding vascular
conditions and potentially obviating DSA in the future. 4D-
Table 4 Detection of lesion size by 4D-CTA and DSA
Author Biswas et al. Wang et al. Willems et al. Singh et al.
Modality 4D-CTA DSA 4D-CTA DSA 4D-CTA DSA 4D-CTA DSA
AVM/DAVF detected 7 10 17 17 17 17 18 18
Lesion size < 3 5 8 7 7 12 12 13 13
3–6 cm 2 2 9 9 5 5 5 5
> 6 cm 0 0 1 1 0 0 N/A N/A
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CTAprovides a large data set of images and thorough review of
all images may help to reduce false-negative cases. For future
studies, it would be prudent to assess inter-rater reliability to
avoid the introduction of any potential errors that may be pro-
ducing the observed variability [19]. The level of training for
reading 4D-CTA scans should also be standardised across cen-
tres to reduce any potential discrepancies, particularly in non-
specialist district general hospitals. Additionally, the small
number of patients included in the studies reviewed renders it
difficult to reach a definite conclusion, which warrants further
large-scale studies in this area.
Conclusion
Due to the restricted number of patients and study heterogeneity
for 3 out of the 4 studies (100% sensitivity and specificity were
reached), performing a meta-analysis was not feasible.
Therefore, the literature was assessed qualitatively. The outcome
from the 4 studies evaluated above has demonstrated that in the
majority of patient cases, 4D-CTA is equally as good as IA-DSA
in excluding the vascular causes of haematoma, although there
are still issues with the classification of the finer
angioarchitectural structures. The lack of relevant studies and
the small number of patients included in the four studies
reviewed has also highlighted that it would be advantageous to
perform further studies comparing 4D-CTAwith DSA in larger
prospective patient cohorts to increase the evidence base which
would inform clinical decision making in patients with sponta-
neous ICH.
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